T1D is related to inflammation, and hence, it is reasonable to speculate that increased levels of IL-10 obtained in serum and pancreas of NOD mice treated with the genetically modified L. lactis encoding IL-4 and IL-10 was at least initially due to the bacteria administration and subsequent expression of these cytokines. The gene discussed is IL10; the disease is type 1 diabetes mellitus.